Unknown

Dataset Information

0

Chronic Oral L-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions.


ABSTRACT: Recent studies have implicated trimethylamine N-oxide (TMAO) in atherosclerosis, raising concern about L-carnitine, a common supplement for patients with inborn errors of metabolism (IEMs) and a TMAO precursor metabolized, in part, by intestinal microbes. Dietary meat restriction attenuates carnitine-to-TMAO conversion, suggesting that TMAO production may not occur in meat-restricted individuals taking supplemental L-carnitine, but this has not been tested. Here, we mine a metabolomic dataset to assess TMAO levels in patients with diverse IEMs, including organic acidemias. These data were correlated with clinical information and confirmed using a quantitative TMAO assay. Marked plasma TMAO elevations were detected in patients treated with supplemental L-carnitine, including those on a meat-free diet. On average, patients with an organic acidemia had ~45-fold elevated [TMAO], as compared to the reference population. This effect was mitigated by metronidazole therapy lasting 7 days each month. Collectively, our data show that TMAO production occurs at high levels in patients with IEMs receiving oral L-carnitine. Further studies are needed to determine the long-term safety and efficacy of chronic oral L-carnitine supplementation and whether suppression or circumvention of intestinal bacteria may improve L-carnitine therapy.

SUBMITTER: Miller MJ 

PROVIDER: S-EPMC5110437 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic Oral L-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions.

Miller Marcus J MJ   Bostwick Bret L BL   Kennedy Adam D AD   Donti Taraka R TR   Sun Qin Q   Sutton V Reid VR   Elsea Sarah H SH  

JIMD reports 20160303


Recent studies have implicated trimethylamine N-oxide (TMAO) in atherosclerosis, raising concern about L-carnitine, a common supplement for patients with inborn errors of metabolism (IEMs) and a TMAO precursor metabolized, in part, by intestinal microbes. Dietary meat restriction attenuates carnitine-to-TMAO conversion, suggesting that TMAO production may not occur in meat-restricted individuals taking supplemental L-carnitine, but this has not been tested. Here, we mine a metabolomic dataset to  ...[more]

Similar Datasets

| S-EPMC7676756 | biostudies-literature
| S-EPMC9830015 | biostudies-literature
| S-EPMC3797917 | biostudies-literature
| S-EPMC4255476 | biostudies-literature
| S-EPMC7074160 | biostudies-literature
| S-EPMC10322682 | biostudies-literature
| S-EPMC4375125 | biostudies-literature
| S-EPMC7144769 | biostudies-literature
2009-07-04 | E-GEOD-16346 | biostudies-arrayexpress
| PRJEB66719 | ENA